Jennifer McDevitt

Jennifer McDevitt is a seasoned professional in clinical sciences with extensive experience in the biotechnology sector. Currently serving as Vice President of Clinical Sciences at ArsenalBio since August 2021, Jennifer previously held the position of Senior Study Director in Clinical Development at Allogene Therapeutics from January 2019 to July 2021. Jennifer's career in clinical sciences also includes a role as Vice President of Clinical Sciences at Tempest Therapeutics from December 2017 to January 2019, and a significant tenure at MedImmune from January 2009 to November 2017, where Jennifer worked as Director, Clinical Scientist.